Plasma plasminogen activator inhibitor-1 activity in normoglycemic hypertriglyceridemic North Asian Indian subjects: A preliminary case-control study

Indian Heart Journal

Volumn 53, Issue 1, 2001, Pages 61-65

  Sarkar, Rupa ^a   Misra, Anoop ^a   Saxena, Renu ^a   Pandey, Ravindra M ^a   Chaudhary, Debashish ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Hypertriglyceridemia; Obesity; Plasminogen activators

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ARTICLE; ASIAN; BLOOD; CASE CONTROL STUDY; CAUCASIAN; HUMAN; HYPERINSULINISM; HYPERTRIGLYCERIDEMIA; INDIA; INSULIN RESISTANCE; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; HYPERINSULINISM; HYPERTRIGLYCERIDEMIA; INDIA; INSULIN RESISTANCE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 0035223644     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Okapcova J, Hrnciar J. The insulin resistance syndrome and fibrinolysis disorders. Vnitr-Lek 1997; 43: 373-378
2. Hiraga T, Shimada M, Tsukada T, Murse T. Hypertriglyceridemia, but not hypercholesterolemia is associated with the alteration of fibrinolytic system. Horm Metab Res 1996; 28: 603-606
3. Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 2000; 283: 221-228
4. Potter van Loon BJ, Kluft C, Radder JK, Blankenstein MA, Meinders AE. The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism 1993; 42: 945-949
5. Durnin JVGA, Womersely J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32: 77-97
6. Kuriyan R, Petracchi C, Ferro-Luzzi A, Kurpad V. Validation of expedient methods for measuring body composition in Indian adults. Indian J Med Res 1998; 107: 37-45
7. World Health Organization. Obesity: Prevention and managing the global epidemic. Report of WHO consultation of obesity. WHO/NUT/NCD/98.1, Geneva 1998
8. Misra A, Raghu C, Reddy KS, Mohan A, Bajaj JS. Hyperinsulinemia and dyslipidemia in non-obese normotensive children of hypertensive patients in Northern India. Blood Pressure 1999, 8: 1-5
9. Mehta J, Mehta P, Lawson D, Saldeen T. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentration. J Am Coll Cardiol 1987; 9: 263-268
10. Mykkanen L, Ronnemaa T, Marniemi J, Haffner SM, Bergman R, Laakso M. Insulin sensitivity is not an indepedent determinant of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 1994; 14: 1264-1271
11. Carlson A, Hamsten A, Wiman B, Carlson LA. Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridemic men. Diabetologia 1993; 36: 817-825
12. Geppert A, Graf S, Beckmann R, Hornykewyez S, Schuster E, Binder BR, et al. Concentration of endogenous tPA antigen in coronary artery disease in relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease. Arterioscler Thromb Vasc Biol 1998; 18: 1634-1642
13. Cigolini M, Targher G, Seidell JC, Schiavon R, Manara F, Zenti MG, et al. Relationship of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men. Atherosclerosis 1994; 106: 139-147
14. Bastard JP, Pieroni L, Hanique B. Relationship between plasma plasminogen activator 1 and insulin resistance. Diabetes Metab Res Rev 2000; 16: 192-201
15. Hughes K, Aw TC, Kuperan P, Choo M. Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health 1997; 51: 394-399.
16. Alessi MC, Juhan-Vague I, Kooistra T, Declerk PJ, Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor-1 by the human hepatocellular cell line Hep G2. Thromb Haemost 1998; 60: 491-494
17. Vague I, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P. Increased plasminogen activator inhibitor activity in non-insulin dependent diabetic patients - relationship with plasma insulin. Thromb Haemost 1989; 61: 370-373
18. Sirtori CR. The physiopathology and pharmacological approach to multiple metabolic and blood coagulation syndromes, the characteristics of atherogenesis. Cardiologia 1991; 36 (Suppl 1): 7-14